Ting Wang advises Chinese and multinational clients on corporate matters including cross-border mergers and acquisitions, securities offerings in Hong Kong and New York, joint ventures in the entertainment and theme park industry, as well as private equity transactions. In addition, he represents corporate clients in the resolution of complex cross-border disputes through arbitration (Hong Kong International Arbitration Centre (HKIAC) and China International Economic and Trade Arbitration Commission (CIETAC)) and litigation, especially the coordination of strategy across multiple jurisdictions (Hong Kong, Mainland China, U.S. federal and state courts). Mr. Wang also represents U.S. listed companies in SEC enforcement actions and internal investigations of securities and accounting fraud, assists acquirors in managing risks in target companies pre- and post-merger, and develops and implements compliance programs for listed and joint venture companies. Mr. Wang also has experience with structured financial products (credit default swaps and collateralized debt obligations).
Prior to joining Paul Hastings, Mr. Wang practiced with another leading international law firm in Washington, D.C., Hong Kong and Beijing. He has also clerked for Judge John M. Walker, Jr., U.S. Court of Appeals for the Second Circuit; Judge Dora L. Irizarry, U.S. District Court for the Eastern District of New York; and Judge George B. Daniels, U.S. District Court for the Southern District of New York.
As the coordinator for law and economics initiatives at the National Committee on U.S.-China Relations, Mr. Wang launched several Track II dialogues on the rule of law and economics between the two countries. As an honors intern at the U.S. Department of the Treasury, he advised the Treasury Secretary on legal matters relating to the World Bank, International Monetary Fund and the Committee on Foreign Investment in the United States (CFIUS).
Mr. Wang received his A.B. (magna cum laude) in Government and A.M. in Regional Studies East Asia from Harvard University and J.D. from Yale Law School. He is a member of New York, District of Columbia and New Jersey bars. He is a native speaker of English and Mandarin Chinese and is conversant in French.
Fosun Pharma and BioNTech Form COVID-19 Vaccine Strategic Alliance in China
March 18, 2020
Paul Hastings Continues HK Biotech IPO Spree with SinoMab BioScience’s Debut
November 12, 2019
Fosun Pharma Sells US$523.15 Million Stake in United Family Healthcare
August 01, 2019
Fosun Tourism Group Completes US$428 Million Hong Kong IPO
December 14, 2018
SIIC Environment Completes Dual Primary Listing on Hong Kong Stock Exchange
March 23, 2018
Zhonghong Group Acquires Significant Stake in SeaWorld Entertainment
March 27, 2017
NewQuest Capital Sells China Hydroelectric Corporation to Shenzhen Energy
December 14, 2015
Not a Party, Not a Problem: SCOTUS Rules That Non-Signatories Can Enforce International Arbitration Agreements in U.S. Courts
June 03, 2020
China Modifies Regime on Administration of Outbound Investments
January 23, 2018